Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Article

J Liaquat Uni Med Health Sci. 2009; 8(2): 177-180


Non-Steroidal Anti-Inflammatory Drugs: Identifying the Risk Factors in the Patients

Nasreen Qazi, Ghulam Rasool Mashori, Shaheen Shah, Afshan Abbas, Mohan Perkash Maheshwari and Ghulam Mustafa Dahri.

Abstract
OBJECTIVE: The objective of this study was to identify the risk factors in NSAID users.
STUDY DESIGN AND SETTING: Comparative prospective study, performed at the Department of
Pharmacology and Therapeutics BMSI, JPMC with the collaboration of Departments of Medicine
and Rheumatology JPMC Karachi from February 2008 to August 2008.
MATERIALS AND METHODS: This study was performed on endoscopically diagnosed patients
of NSAID induced peptic ulcers, in whom a clinical trial was performed between Ranitidine (H2
Receptor blocker) and new proton pump inhibitor Esomeprazole. Eighty Patients were selected
and evaluated for presence of risk factors and dyspepsia after consumption of NSAIDs or low
dose aspirin for last 6 months to 1 year. They were asked to fill in a specially designed proforma
regarding the use of NSAIDs, which also included the questions for their social setup, habits
and diseases for which they were taking them. All the patients were tested for presence of H.
pylori infection and anti-H. pylori IgG antibody titers were determined by enzyme-linked immunosorbent
assay. Patients taking anticoagulants and steroids were excluded from the study.
RESULTS: Important factors that have been shown to increase the risk of NSAID-associated GI
complications in our study included female gender (76%) presence of H.pylori infection (71%),
combination of two NSAIDs (23.75%) and high-dose NSAID use (20%). Other factors that may
increase risk include social habits like heavy consumption of tea (30%), pan or Gutka consumption
(8.75%). Current evidence supports that H. pylorus potentates the risk of NSAID-induced
gastrointestinal ulcers or clinical events, and a strategy of H. pylori testing and treatment in
NSAID users may be adopted.
CONCLUSIONS: The incidence of NSAID related gastrointestinal problems was present in 10-
15% of patients who belonged to high risk group. Identifying them is strongly recommended to
avoid serious complications. H. pylori infection may also be eradicated before initiating NSAID
therapy.

Key words: Non-steroidal anti-inflammatory drugs (NSAIDs), Helicobacter pylori (H. pylori), Gastrointestinal (GI).



Share this Article


Advertisement
American Journal of Research in Medical Sciences

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons